Profound Medical Corp. Files 6-K with Press Release
Ticker: PROF · Form: 6-K · Filed: Oct 16, 2024 · CIK: 1628808
| Field | Detail |
|---|---|
| Company | Profound Medical Corp. (PROF) |
| Form Type | 6-K |
| Filed Date | Oct 16, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-K, press-release
TL;DR
Profound Medical Corp. dropped a 6-K with a press release on Oct 16, 2024.
AI Summary
Profound Medical Corp. filed a Form 6-K on October 16, 2024, to report a press release dated the same day. The press release, attached as Exhibit 99.1, is the primary content of this filing.
Why It Matters
This filing indicates Profound Medical Corp. is providing updated information to the SEC, likely related to recent business developments or announcements shared in the press release.
Risk Assessment
Risk Level: low — This filing is a routine report of a press release and does not contain new financial data or significant operational changes.
Key Players & Entities
- Profound Medical Corp. (company) — Filer of the 6-K
- October 16, 2024 (date) — Date of the press release and filing
- 2400 Skymark Avenue, Unit 6, Mississauga, Ontario L4W 5K5 (address) — Principal executive office address
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is filed by foreign private issuers to report information that they have made or are required to make public pursuant to the laws of their home country, or that they have filed or are required to file with a stock exchange on which their securities are traded.
What is included as an exhibit in this 6-K filing?
Exhibit 99.1, a press release dated October 16, 2024, is attached to this 6-K filing.
What is the SEC file number for Profound Medical Corp.?
The SEC file number for Profound Medical Corp. is 001-39032.
What is the principal executive office address for Profound Medical Corp.?
The principal executive office address is 2400 Skymark Avenue, Unit 6, Mississauga, Ontario L4W 5K5.
Does Profound Medical Corp. file annual reports under Form 20-F or Form 40-F?
Profound Medical Corp. files annual reports under Form 40-F.
Filing Stats: 165 words · 1 min read · ~1 pages · Grade level 12.9 · Accepted 2024-10-16 16:30:04
Filing Documents
- f6k_101624.htm (6-K) — 4KB
- exh_991.htm (EX-99.1) — 11KB
- 0001171843-24-005661.txt ( ) — 17KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. PROFOUND MEDICAL CORP. (Registrant) Date: October 16, 2024 /s/ Rashed Dewan Rashed Dewan Chief Financial Officer